GRI Bio (GRI) Fundamental Analysis: Revenue, Earnings & Valuation

1.46 / 10

Underperform

Fundamentals are underperforming with a 1.5/10 rating. Revenue growth is strong yet unsustainable, while current liabilities dominate total liabilities (95.8%). Interest coverage and inventory turnover are modest positives, but overall financial health is weak.

Analysis Checks(5/7)

Total operating revenue (YoY growth rate %)

Value123.10

Score2/3

Weight-1.15%

1M Return0.13%

Inventory turnover ratio

Value53.12

Score2/3

Weight9.51%

1M Return-1.18%

Current liabilities / Total liabilities (%)

Value95.84

Score0/3

Weight35.23%

1M Return-4.96%

Long-term debt to working capital ratio (%)

Value0.02

Score2/3

Weight2.95%

1M Return-0.35%

Interest coverage ratio (EBIT / Interest expense) (%)

Value65.69

Score2/3

Weight9.67%

1M Return-1.17%

Operating revenue (YoY growth rate %)

Value138.18

Score0/3

Weight34.65%

1M Return-4.63%

Cost of sales ratio (%)

Value71.87

Score2/3

Weight9.14%

1M Return-1.13%

Is GRI fundamentally strong?

GRI scores 1.46/10 on fundamentals and holds a Premium valuation at present. Backed by its -238.17% ROE, 0.00% net margin, -0.28 P/E ratio, 0.56 P/B ratio, and 92.12% earnings growth, these metrics solidify its Underperform investment rating.